Allurion TechnologiesALURD -2.11%16 Days Inventory is 125.64 as of Mar. 2026, which is 18% below its 10-year median of 153.01. GuruFocus rates ALURD with a GF Score™ of 16/100 and a GF Value™ of $10.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Allurion Technologies ranks worse than 53.94% on this metric.
The historical rank and industry rank for Allurion Technologies's Days Inventory or its related term are showing as below:
ALURD'
s Days Inventory Range Over the Past 10 Years
Min: 89.05 Med: 153.01 Max: 195.75
Current: 190.13
During the past 5 years, Allurion Technologies's highest Days Inventory was 195.75. The lowest was 89.05. And the median was 153.01.
ALURD's Days Inventory is ranked worse than 53.94% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.86
vs ALURD: 190.13
Allurion Technologies's Days Inventory
declined
from Mar. 2025 (217.10) to Mar. 2026 (125.64).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Allurion Technologies's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.73.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Allurion Technologies's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.80.
Allurion Technologies (OTCPK:ALURD) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Allurion Technologies's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Allurion Technologies's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Allurion Technologies Days Inventory Related Terms
Allurion Technologies Days Inventory Historical Data
* Premium members only.
The historical data trend for Allurion Technologies's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ALURD vs ALRTF, VVOS, SINT: Days Inventory Comparison
For the Medical Devices subindustry, Allurion Technologies's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Allurion Technologies Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Allurion Technologies's Days Inventory distribution charts can be found below:
* The bar in red indicates where Allurion Technologies's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Allurion Technologies (ALURD) has a Days Inventory of 125.64 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Allurion Technologies and its competitors. This is 18% below median its historical median of 153.01. Over the past decade, Allurion Technologies' Days Inventory has ranged from 89.05 to 195.75. According to the industry distribution chart, Allurion Technologies ranks #424 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 53.9%.
Is Allurion Technologies' Days Inventory too high?
Allurion Technologies' current Days Inventory of 125.64 is 18% below median its 10-year median of 153.01. Over the past 10 years, this metric has ranged from a low of 89.05 to a high of 195.75. The Medical Devices & Instruments industry median Days Inventory is 179.86. Allurion Technologies' value of 125.64 is 30.1% below this industry median. Based on the distribution chart, Allurion Technologies ranks #424 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Allurion Technologies has a GF Score™ of 16/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Allurion Technologies' Days Inventory compare to ALRTF and VVOS?
According to the Medical Devices & Instruments industry distribution chart, Allurion Technologies ranks #424 out of 786 companies for Days Inventory. This places Allurion Technologies in the lower half of its industry. The industry median Days Inventory is 179.86. Allurion Technologies' value of 125.64 is 30.1% below this benchmark. Historically, Allurion Technologies' own Days Inventory has ranged from 89.05 to 195.75 over the past decade. While the company's 10-year median is 153.01 vs. the industry median of 179.86, Allurion Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.86, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Allurion Technologies's current Days Inventory of 125.64 is 30.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Allurion Technologies and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Allurion Technologies's current Days Inventory is 125.64, which is 18% below median its own 10-year median of 153.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allurion Technologies stock overvalued right now?
Based on GuruFocus' analysis, Allurion Technologies (ALURD) is currently considered Possible Value Trap. The stock's GF Value™ is $10.66, compared to a current price of $5.91 — trading 44.6% below its estimated fair value. The current Days Inventory is 125.64, which is 18% below median its 10-year median of 153.01 and 30.1% below the Medical Devices & Instruments industry median of 179.86. Allurion Technologies' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Allurion Technologies (ALURD), the current Days Inventory is 125.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Allurion Technologies (ALURD) Overvalued in 2026?
Based on GuruFocus' analysis, Allurion Technologies stock appears to be undervalued.
The current stock price of $5.91 is trading 44.6% below its estimated GF Value™ of $10.66.
GuruFocus considers Allurion Technologies to be Possible Value Trap.
Key valuation signals for ALURD:
Days Inventory: 125.64 (18% below median its 10-year median of 153.01)
GF Value™: $10.66 vs. price of $5.91 (44.6% below fair value)
Industry Position: 30.1% below the Medical Devices & Instruments median (#424 of 786)
No single metric tells the full story. See the ALURD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
16GF Score
Get the complete analysis for ALURD
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALURD has been successfully added to your 
